Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patient selection for thrombolytic therapy.

A G Wasserman1, A M Ross

  • 1George Washington University Medical Center, Washington, D.C. 20037.

The American Journal of Cardiology
|July 18, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observations on Dental Caries.

International dental journal (Philadelphia, Pa.)·2023
Same author

Connecticut Valley Dental Society.

The Independent practitioner·2023
Same author

Theory vs. Facts.

The Independent practitioner·2023
Same author

A Class of Pulpless Teeth-Their Treatment.

The Independent practitioner·2023
Same author

Crown Work.

The Independent practitioner·2023
Same author

Epithelioma.

The Independent practitioner·2023
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Thrombolytic therapy significantly reduces mortality in acute myocardial infarction patients by up to 52%. However, optimal patient selection requires further research regarding time windows, infarction site, ECG criteria, and elderly care.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute myocardial infarction (AMI) is a leading cause of mortality worldwide.
  • Thrombolytic therapy has demonstrated significant mortality reduction in AMI patients.
  • Optimal patient selection criteria for thrombolytic therapy remain under investigation.

Purpose of the Study:

  • To review the current evidence on thrombolytic therapy in AMI.
  • To identify unresolved patient selection issues for effective thrombolytic treatment.
  • To highlight areas for future research in optimizing thrombolytic therapy.

Main Methods:

  • Literature review of recent studies on thrombolytic therapy for AMI.
  • Analysis of patient selection factors including time window, infarction site, and electrocardiographic criteria.

Related Experiment Videos

  • Examination of treatment considerations for elderly AMI patients.

    • Main Results:

    • Thrombolytic therapy can decrease AMI mortality by 20% to 52%.
    • Key unresolved issues include determining optimal time windows for therapy.
    • Further research is needed on site-specific, ECG-based, and age-specific treatment strategies.

    Conclusions:

    • Thrombolytic therapy is a crucial intervention for reducing AMI mortality.
    • Refining patient selection criteria is essential for maximizing therapeutic benefits.
    • Addressing specific patient subgroups, such as the elderly, requires tailored approaches.